Cargando…

Loss of p16(INK4A) stimulates aberrant mitochondrial biogenesis through a CDK4/Rb-independent pathway

The tumor suppressor p16INK4A (p16) inhibits cell cycle progression through the CDK4/Rb pathway. We have previously shown that p16 regulates cellular oxidative stress, independent of its role in cell cycle control. We investigated whether loss of p16 had a direct impact on the mitochondria. We found...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tyagi, Ethika, Liu, Bin, Li, Chelsea, Liu, Tong, Rutter, Jared, Grossman, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593528/ https://www.ncbi.nlm.nih.gov/pubmed/28915557 http://dx.doi.org/10.18632/oncotarget.19862

Ejemplares similares

The interplay of CDK4 and CDK6 in melanoma
por: Kollmann, Karoline, et al.
Publicado: (2019)

A novel suicide gene therapy for the treatment of p16(Ink4a)-overexpressing tumors
por: Kohli, Jaskaren, et al.
Publicado: (2017)

Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cells
por: Litchfield, Lacey M., et al.
Publicado: (2020)

CDK6 and p16(INK4A) in lymphoid malignancies
por: Kollmann, Karoline, et al.
Publicado: (2013)

CDK6 Degradation Is Counteracted by p16(INK4A) and p18(INK4C) in AML
por: Schmalzbauer, Belinda S., et al.
Publicado: (2022)

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
por: Perez, Marco, et al.
Publicado: (2015)

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition
por: Gopalan, Priya K., et al.
Publicado: (2018)

Mutation testing in melanoma families: INK4A, CDK4 and INK4D
por: Newton Bishop, J A, et al.
Publicado: (1999)

Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer
por: Witkiewicz, Agnieszka K., et al.
Publicado: (2015)

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells
por: De Luca, Arianna, et al.
Publicado: (2015)

Simulation of Different Truncated p16(INK4a) Forms and In Silico Study of Interaction with Cdk4
por: Fahham, Najmeh, et al.
Publicado: (2008)

Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2- breast cancer
por: Knudsen, Erik S., et al.
Publicado: (2016)

Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature
por: Knudsen, Erik S., et al.
Publicado: (2017)

The p16(INK4A) tumor suppressor regulates cellular oxidative stress
por: Jenkins, Noah C., et al.
Publicado: (2010)

P1412: UNCOUPLING INK4 PROTEINS FROM CDK4/CDK6 IN HEMATOPOIETIC STEM CELLS
por: Schirripa, A., et al.
Publicado: (2022)

Irreversibility of cellular senescence: dual roles of p16(INK4a)/Rb-pathway in cell cycle control
por: Takahashi, Akiko, et al.
Publicado: (2007)

c-JUN prevents methylation of p16INK4a (and Cdk6): the villain turned bodyguard
por: Kollmann, Karoline, et al.
Publicado: (2011)

Aberrations of the p14(ARF) and p16(INK4a) Genes in Renal Cell Carcinomas
por: Kawada, Yoichi, et al.
Publicado: (2001)

Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer
por: Zhao, Weiqiang, et al.
Publicado: (2012)

Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7
por: Keijzers, Marlies, et al.
Publicado: (2015)

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
por: Li, Qing, et al.
Publicado: (2022)

Firing of Replication Origins Is Disturbed by a CDK4/6 Inhibitor in a pRb-Independent Manner
por: Kim, Su-Jung, et al.
Publicado: (2023)

NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
por: Wu, Nan, et al.
Publicado: (2016)

Aberrant DNA methylation of the p16(INK4a) gene in plasma DNA of breast cancer patients
por: Silva, J M, et al.
Publicado: (1999)

Detection of Aberrant p16(INK4A) Methylation in Sera of Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Chu, Hyung Jun, et al.
Publicado: (2004)

The blues of P(16)INK(4a): Aberrant promoter methylation and association with colorectal cancer in the Kashmir valley
por: SAMEER, A. SYED, et al.
Publicado: (2012)

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
por: Maelandsmo, G. M., et al.
Publicado: (1996)

P16(INK4A) expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
por: Ishikawa, Masako, et al.
Publicado: (2021)

CDKN2A (p16(INK4A)) affects the anti-tumor effect of CDK inhibitor in somatotroph adenomas
por: Chen, Yiyuan, et al.
Publicado: (2021)

The BRD4–NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma
por: Durall, R. Taylor, et al.
Publicado: (2023)

Aberrant p16INK4A methylation: Relation to viral related chronic liver disease and hepatocellular carcinoma
por: El-Mougy, Fatma A., et al.
Publicado: (2014)

p16INK4a in cellular senescence
por: Simboeck, Elisabeth, et al.
Publicado: (2013)

p16(INK4a) Expression in Porokeratosis
por: Uryu, Miki, et al.
Publicado: (2017)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons
por: Veas-Pérez de Tudela, Miguel, et al.
Publicado: (2015)

CDK4, pRB and E2F1: connected to insulin
por: Fajas, Lluis, et al.
Publicado: (2010)

The effects of transferring tumor suppressor gene p16(INK4A) to p16(INK4A)-deleted cancer cells*
por: Lee, Kye Young, et al.
Publicado: (1999)

Culturing on Wharton's Jelly Extract Delays Mesenchymal Stem Cell Senescence through p53 and p16INK4a/pRb Pathways
por: Hao, Haojie, et al.
Publicado: (2013)

Epstein-Barr virus LMP1 blocks p16(INK4a)–RB pathway by promoting nuclear export of E2F4/5
por: Ohtani, Naoko, et al.
Publicado: (2003)

p16(INK4A)-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases
por: Ni, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8s6hnrntvjn0lcgsi35sg3tqu